NIH VideoCast - Heterologous Prime/Boost Covid-19 Vaccine Schedules Emerging Data From the COM-COV and COM-Boost Studies

Skip Navigation

Heterologous Prime/Boost Covid-19 Vaccine Schedules Emerging Data From the COM-COV and COM-Boost Studies

Loading... Loading video...

391 Views

Air date:	Thursday, January 20, 2022, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 391 (310 Live, 81 On-demand)
Category:	COVID-19
Runtime:	00:59:27
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	COVID-19 Lecture Matthew Snape, MBBS FRCPCH MD, is an Professor in General Paediatrics and Vaccinology at the Oxford Vaccine Group, University of Oxford Department of Paediatrics and the NIHR Oxford Biomedical Research Council. He is also a Jenner Investigator and works as a General Paediatrician at the Children’s Hospital Oxford, Oxford University Hospitals NHS Trust. Lecture objectives will be (1) Understanding potential rationale for use of mixed COVID-19 vaccine schedules, (2) Review of the available immunogenicity and safety data, with particular focus on the COMCOV and COV-Boost studies, and (3) Relevance for Variants of Concern and persistence of immunity. For more information go to https://www.niaid.nih.gov/research/covid-19-sig

NLM Title:	Heterologous prime/boost COVID-19 vaccine schedules : emerging data from the COM-COV and COM-boost studies / Matthew Snape.
Author:	Snape, Matthew. National Institutes of Health (U.S.). COVID-19 Scientific Interest Group,
Publisher:
Abstract:	(CIT): Matthew Snape, MBBS FRCPCH MD, is an Professor in General Pediatrics and Vaccinology at the Oxford Vaccine Group, University of Oxford Department of Pediatrics and the NIHR Oxford Biomedical Research Council. He is also a Jenner Investigator and works as a General Pediatrician at the Children's Hospital Oxford, Oxford University Hospitals NHS Trust. Lecture objectives will be (1) Understanding potential rationale for use of mixed COVID-19 vaccine schedules, (2) Review of the available immunogenicity and safety data, with particular focus on the COMCOV and COV-Boost studies, and (3) Relevance for Variants of Concern and persistence of immunity.
Subjects:	COVID-19 Vaccines--administration & dosage COVID-19 Vaccines--immunology COVID-19--drug therapy Immunization Schedule Immunization, Secondary Vaccine Efficacy
Publication Types:	Lecture Webcast

NLM Classification:	WC 506.6
NLM ID:	9918351572506676
CIT Live ID:	44521
Permanent link:	https://videocast.nih.gov/watch=44521

Related Videos...